Mortality among adults living with HIV treated for tuberculosis based on positive, negative, or no bacteriologic test results for tuberculosis: the IeDEA consortium
暂无分享,去创建一个
C. Yiannoutsos | K. Anastos | M. Yotebieng | L. Diero | T. Sterling | E. Carter | K. Wools-Kaloustian | B. Musick | A. Pettit | E. Messou | B. Crabtree-Ramírez | P. Mpofu | Olivier Marcy | J. Humphrey | O. Marcy
[1] T. Sterling,et al. HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease. , 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[2] M. Egger,et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries , 2018, bioRxiv.
[3] X. Bi,et al. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis , 2018, Emerging Microbes & Infections.
[4] K. Naidoo,et al. Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa , 2018, BMC Infectious Diseases.
[5] Timothy M Wolock,et al. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 , 2017, The Lancet. Infectious diseases.
[6] M. Borgdorff,et al. Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya , 2017, PloS one.
[7] P. Onyebujoh,et al. Stronger tuberculosis laboratory networks and services in Africa essential to ending tuberculosis , 2017, African journal of laboratory medicine.
[8] M. Yotebieng,et al. Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program , 2017, PloS one.
[9] G. Medhin,et al. Factors Associated with Mortality of TB/HIV Co-infected Patients in Ethiopia , 2017, Ethiopian journal of health sciences.
[10] Isabel K. M. Yan,et al. Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis , 2016, PloS one.
[11] Jeffrey N. Martin,et al. Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda , 2016, Journal of acquired immune deficiency syndromes.
[12] S. Lawn,et al. Xpert MTB/RIF - why the lack of morbidity and mortality impact in intervention trials? , 2016, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[13] M. Lindegren,et al. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries , 2016, PloS one.
[14] D. Silva,et al. Characteristics of Patients with Smear-Negative Pulmonary Tuberculosis (TB) in a Region with High TB and HIV Prevalence , 2016, PloS one.
[15] M. Noubom,et al. Determinants of death among tuberculosis patients in a semi urban diagnostic and treatment centre of Bafoussam, West Cameroon: a retrospective case-control study , 2015, The Pan African medical journal.
[16] S. Lawn,et al. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis , 2015, AIDS.
[17] Alimuddin Zumla,et al. Tackling the tuberculosis epidemic in sub-Saharan Africa--unique opportunities arising from the second European Developing Countries Clinical Trials Partnership (EDCTP) programme 2015-2024. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[18] B. Lindtjørn,et al. Trends of Tuberculosis Case Notification and Treatment Outcomes in the Sidama Zone, Southern Ethiopia: Ten-Year Retrospective Trend Analysis in Urban-Rural Settings , 2014, PloS one.
[19] L. Rodrigues,et al. Empirical treatment for TB in HIV: lessons from a cohort study of people living with HIV treated in Recife, Brazil , 2014, BMC Public Health.
[20] P. Mason,et al. Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial , 2014, Open forum infectious diseases.
[21] Grant Theron,et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial , 2014, The Lancet.
[22] K. Anastos,et al. Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and Screening , 2013, PloS one.
[23] L. Scott,et al. Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa , 2013, PloS one.
[24] Denis Nash,et al. TB Diagnostic Capacity in Sub-Saharan African HIV Care Settings , 2012, Journal of acquired immune deficiency syndromes.
[25] Kara Wools-Kaloustian,et al. Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. , 2012, International journal of epidemiology.
[26] M. Lourenço,et al. Factors Impacting Early Mortality in Tuberculosis/HIV Patients: Differences between Subjects Naïve to and Previously Started on HAART , 2012, PloS one.
[27] F. Altice,et al. Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients , 2012, International journal of STD & AIDS.
[28] F. Behets,et al. Mortality among tuberculosis patients in the Democratic Republic of Congo. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[29] R. Chaisson,et al. Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis , 2012, PLoS medicine.
[30] S. McCormack,et al. The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK , 2012, International journal of STD & AIDS.
[31] R. Walensky,et al. Loss to Follow-Up and Mortality Among HIV-Infected People Co-Infected With TB at ART Initiation in Durban, South Africa , 2012, Journal of acquired immune deficiency syndromes.
[32] Y. Manabe,et al. Strengthening Public Laboratory Service in Sub-Saharan Africa: Uganda Case Study , 2011 .
[33] M. Dimairo,et al. Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[34] Eduardo Gotuzzo,et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study , 2011, The Lancet.
[35] S. Squire,et al. A systematic review of risk factors for death in adults during and after tuberculosis treatment. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[36] J. Nkengasong,et al. Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities , 2011, Clinical Microbiology Reviews.
[37] Philippe Glaziou,et al. Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment , 2011, Clinical epidemiology.
[38] W. Fawzi,et al. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis , 2009, BMC public health.
[39] S. Akksilp,et al. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[40] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[41] L. Thomson,et al. A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[42] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.
[43] G. Bjune,et al. A systematic review of delay in the diagnosis and treatment of tuberculosis , 2008, BMC public health.
[44] J. Musser,et al. Mortality associated with central nervous system tuberculosis. , 2007, The Journal of infection.
[45] Matthias Egger,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.
[46] Paul Nunn,et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes , 2007, The Lancet.
[47] Stef van Buuren,et al. Multiple imputation of discrete and continuous data by fully conditional specification , 2007 .
[48] E. Kourbatova,et al. Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US , 2006, European Journal of Epidemiology.
[49] A. Harries,et al. Mortality in smear-negative tuberculosis patients in Phalombe. , 2004, Malawi medical journal : the journal of Medical Association of Malawi.
[50] E Declercq,et al. Optimal tuberculosis case detection by direct sputum smear microscopy: how much better is more? , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[51] C. Whitty,et al. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[52] A. Harries,et al. What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence? , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[53] A. Harries,et al. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa , 2001, AIDS.
[54] S. Lawn,et al. Pulmonary tuberculosis in adults: factors associated with mortality at a Ghanaian teaching hospital. , 1999, West African journal of medicine.
[55] A. Banerjee,et al. Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[56] S. Hulley,et al. Predictors of Mortality among HIV-infected Women in Kigali, Rwanda , 1992, Annals of Internal Medicine.
[57] D. Rubin. Multiple imputation for nonresponse in surveys , 1989 .
[58] C. Dolea,et al. World Health Organization , 1949, International Organization.
[59] Vital Hepatitis Std Aids,et al. Reported tuberculosis in the United States 2013 , 2014 .
[60] A. Harries,et al. Tuberculosis and HIV: current status in Africa. , 1997, AIDS.